Influence of implantation site and track geometry on the extrusion rate and pharmacology of testosterone implants

Clinical Endocrinology

Volumn 55, Issue 4, 2001, Pages 531-536

  Kelleher, S ^a   Conway, A J ^a   Handelsman, D J ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ANZAC RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE;

ABDOMINAL WALL; ADULT; ANATOMICAL VARIATION; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CAPILLARY RESISTANCE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG IMPLANTATION; DRUG RELEASE; FOLLITROPIN BLOOD LEVEL; GEOMETRY; HIP; HORMONE DEFICIENCY; HORMONE DETERMINATION; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; INFECTION; LUTEINIZING HORMONE BLOOD LEVEL; MALE; PELLET EXTRUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL;

ABDOMEN; ANDROGENS; AREA UNDER CURVE; DRUG IMPLANTS; FOLLICLE STIMULATING HORMONE; HIP; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; LUTEINIZING HORMONE; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; TESTOSTERONE; TREATMENT FAILURE;

EID: 0034797564     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01357.x     Document Type: Article

References (21)

1. Testosterone buciclate (20 Aet-1) in hypogonadal men: Pharmacokinetics and pharmacodynamics of the new long-acting androgen ester
2. A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men
3. Use, misuse and abuse of androgens: The Endocrine Society of Australia consensus guidelines for androgen prescribing
4. Treatment of sexual underdevelopment with synthetic male hormone substance
5. Clinical pharmacology of testosterone pellet implants
6. Androgen action and pharmacologic uses
7. Pharmacokinetics and pharmacodynamics of testosterone pellets in man
8. Pharmacokinetics of human follicle-stimulating hormone in gonadotropin-deficient men
9. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot
10. Analysis of testosterone implants for androgen replacement therapy
11. Testosterone replacement therapy for male hypogonadism with a radiation-polymerized testicular prosthesis
12. Hepatotoxic effects of the anabolic-androgenic steroids
13. Extrusion of testosterone pellets: A randomized controlled clinical study
14. Tolerability of intramuscular injections of testosterone ester in an oil vehicle
15. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men
16. Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: Effects of ester, injection site and injection Volume
17. Transdermal testosterone replacement through genital skin
18. Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men - A clinical research center study
19. Treatment of hypogonadal adolescent boys with long acting subcutaneous testosterone pellets
20. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men